8046255 Canada Inc. DBA Viatrexx
⚠️ High Risk
FEI: 3010033797 • Beloeil, Quebec • CANADA
FEI Number
3010033797
Location
Beloeil, Quebec
Country
CANADAAddress
1360 Louis-Marchand St, , Beloeil, Quebec, Canada
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
INCONSPICU
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
DIETARYLBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FALSE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 8/9/2023 | 65CBQ99NUTRIENT/TONIC N.E.C. | Division of Northern Border Imports (DNBI) | |
| 5/13/2022 | 54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | Division of Northern Border Imports (DNBI) | |
| 5/13/2022 | 54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | Division of Northern Border Imports (DNBI) | |
| 9/22/2021 | 61WBQ99A-FUNGAL N.E.C. | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 64RAQ18HUMAN GROWTH HORMONE (HORMONE) | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 64ABQ08FORMALDEHYDE SOL (DISINFECTANT) | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 60CBY02DOPAMINE HCL (ADRENERGIC) | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 62GBQ99ANTI-INFLAMMATORY N.E.C. | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 65RBQ99REPLENISHER N.E.C. | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | Division of Northern Border Imports (DNBI) | |
| 6/30/2021 | 65RBQ99REPLENISHER N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 61XBQ99ANTI-HISTAMINIC N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 64RAQ18HUMAN GROWTH HORMONE (HORMONE) | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 61KBQ06BELLADONNA (EXT) (ANTI-CHOLINERGIC) | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 65CBQ99NUTRIENT/TONIC N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 64EBQ99ENZYME N.E.C. | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
| 6/30/2021 | 64ABQ08FORMALDEHYDE SOL (DISINFECTANT) | 27DRUG GMPS | Division of Northern Border Imports (DNBI) |
Frequently Asked Questions
What is 8046255 Canada Inc. DBA Viatrexx's FDA import refusal history?
8046255 Canada Inc. DBA Viatrexx (FEI: 3010033797) has 23 FDA import refusal record(s) in our database, spanning from 6/30/2021 to 8/9/2023.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. 8046255 Canada Inc. DBA Viatrexx's FEI number is 3010033797.
What types of violations has 8046255 Canada Inc. DBA Viatrexx received?
8046255 Canada Inc. DBA Viatrexx has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about 8046255 Canada Inc. DBA Viatrexx come from?
All FDA import refusal data for 8046255 Canada Inc. DBA Viatrexx is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.